Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 13
Submit an article Journal homepage
1,940
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Glofitamab CD20-TCB bispecific antibody

Adrian Minsona Clinical Haematology, Peter MacCallum Cancer Centre & Royal Melbourne Hospital, Melbourne, Australia;b Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, AustraliaCorrespondence[email protected]
&
Michael Dickinsona Clinical Haematology, Peter MacCallum Cancer Centre & Royal Melbourne Hospital, Melbourne, Australia;b Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia
Pages 3098-3108 | Received 13 May 2021, Accepted 29 Jun 2021, Published online: 15 Jul 2021

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Karan L. Chohan & Stephen M. Ansell. (2022) The broader prospects for bispecifics in Hodgkin lymphoma. Leukemia & Lymphoma 63:8, pages 1777-1779.
Read now
Marlena Surowka, Wolfgang Schaefer & Christian Klein. (2021) Ten years in the making: application of CrossMab technology for the development of therapeutic bispecific antibodies and antibody fusion proteins. mAbs 13:1.
Read now

Articles from other publishers (4)

Marion Lacroix, Hugues Beauchemin, Cyrus Khandanpour & Tarik Möröy. (2023) The RNA helicase DDX3 and its role in c-MYC driven germinal center-derived B-cell lymphoma. Frontiers in Oncology 13.
Crossref
Thomas E Lew, Adrian Minson, Michael Dickinson, Sasanka M Handunnetti, Piers Blombery, Amit Khot, Mary Ann Anderson, David Ritchie, Constantine S Tam & John F Seymour. (2023) Treatment approaches for patients with TP53-mutated mantle cell lymphoma. The Lancet Haematology 10:2, pages e142-e154.
Crossref
Adrian Minson, Constantine Tam, Michael Dickinson & John F. Seymour. (2022) Targeted Agents in the Treatment of Indolent B-Cell Non-Hodgkin Lymphomas. Cancers 14:5, pages 1276.
Crossref
Fabian Frontzek, Imke Karsten, Norbert Schmitz & Georg Lenz. (2022) Current options and future perspectives in the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma. Therapeutic Advances in Hematology 13, pages 204062072211033.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.